Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Bluejay Diagnostics (BJDX) Invested Capital (2020 - 2026)

Bluejay Diagnostics' Invested Capital history spans 3 years, with the latest figure at $2.9 million for Q4 2023.

  • On a quarterly basis, Invested Capital fell 74.92% to $2.9 million in Q4 2023 year-over-year; TTM through Dec 2023 was $2.9 million, a 74.92% decrease, with the full-year FY2023 number at $2.9 million, down 74.92% from a year prior.
  • Invested Capital hit $2.9 million in Q4 2023 for Bluejay Diagnostics, down from $5.2 million in the prior quarter.
  • Over the last five years, Invested Capital for BJDX hit a ceiling of $20.4 million in Q4 2021 and a floor of $2.9 million in Q4 2023.
  • Historically, Invested Capital has averaged $11.6 million across 3 years, with a median of $11.5 million in 2022.
  • Biggest five-year swings in Invested Capital: crashed 43.38% in 2022 and later plummeted 74.92% in 2023.
  • Tracing BJDX's Invested Capital over 3 years: stood at $20.4 million in 2021, then crashed by 43.38% to $11.5 million in 2022, then plummeted by 74.92% to $2.9 million in 2023.
  • Business Quant data shows Invested Capital for BJDX at $2.9 million in Q4 2023, $5.2 million in Q3 2023, and $6.4 million in Q2 2023.